ClinicalTrials.gg

Program

Beclomethasone

Also written as “Beclomethasone dipropionate”, “Beclometasone/Formoterol/Glycopyrrolate” and “beclomethasone”.

Its studies are mostly in Asthma · Pulmonary Disease, Chronic Obstructive · Rhinitis, Allergic, Seasonal · Rhinitis, Allergic, Perennial · Graft vs Host Disease, led by 7 companies.

Furthest: phase 4, since Oct 28, 202044 company-led studies, 1 open or runningNext primary completion: Jun 2028 (phase 3)

Who develops it

Each company that leads studies of it, as its sponsor page counts them.

CompanyStudies it leadsFurthest phaseFirst studyNext primary completion
Chiesi Farmaceutici220 open or runningphase 4since Oct 28, 2020Sep 29, 2006none ahead
Teva Pharmaceutical Industries140 open or runningphase 4since Oct 28, 2003Oct 28, 2003none ahead
Soligenix30 open or runningphase 3since Jun 19, 2009Jun 19, 2009none ahead
Adamis Pharmaceuticals20 open or runningphase 3since Feb 6, 2019Feb 6, 2019none ahead
Enteron Pharmaceuticals10 open or runningphase 3since Oct 4, 2005Oct 4, 2005none ahead
Lunan Pharmaceutical Group11 open or runningphase 3since Jul 21, 2026Jul 21, 2026Jun 2028phase 3 · NCT07768891
SOFAR10 open or runningphase 1since Apr 26, 2021Apr 26, 2021none ahead

How these companies relate is not in the registry. A license or acquisition is shown only with a dated source, such as a company release or filing.

History and what’s ahead

From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.

Before these, 27 studies since Oct 28, 2003.

  1. Aug 16, 2013Phase 2 study in Chronic Gastrointestinal Graft vs Host DiseaseSoligenix · NCT01925950 · 2 enrolled · United States
  2. Jan 7, 20143 phase 3 studies in AsthmaTeva Pharmaceutical Industries · NCT02031640, NCT02040779, NCT02040766
  3. Jan 9, 2014Phase 1 study in Pulmonary Disease, Chronic ObstructiveChiesi Farmaceutici · NCT02040597 · 42 enrolled · Poland
  4. Apr 11, 2014Phase 1 study in Pulmonary Disease, Chronic ObstructiveChiesi Farmaceutici · NCT02119234 · 36 enrolled · Poland
  5. May 21, 2014Phase 2 study in AsthmaChiesi Farmaceutici · NCT02148120 · 60 enrolled · United Kingdom
  6. Nov 15, 2016Phase 1 study in Pulmonary Disease, Chronic ObstructiveChiesi Farmaceutici · NCT02975843 · 28 enrolled
  7. Aug 23, 2017Phase 3 study in Pulmonary Disease, Chronic ObstructiveChiesi Farmaceutici · NCT03268226 · 20 enrolled · Belgium, Hungary
  8. Feb 6, 2019Adamis Pharmaceuticals's first studies: 2 phase 3 studies in AsthmaNew to Adamis PharmaceuticalsAdamis Pharmaceuticals · NCT03834012, NCT03835871
  9. Oct 28, 2020Phase 4 study in Pulmonary Disease, Chronic ObstructiveChiesi Farmaceutici · NCT04671355
  10. Apr 26, 2021SOFAR's first study: phase 1 study in Healthy Adult Male VolunteersNew to SOFARSOFAR · NCT04873063 · 28 enrolled · Italy
  11. Apr 27, 2021Phase 3 study in AsthmaChiesi Farmaceutici · NCT04886999 · 78 enrolled · Italy
  12. May 3, 2021Phase 3 study in Pulmonary Disease, Chronic ObstructiveChiesi Farmaceutici · NCT04876677 · 25 enrolled · Belgium, Hungary
  13. Mar 4, 2022Phase 3 study in AsthmaChiesi Farmaceutici · NCT05292586 · 1,377 enrolled · United States
  14. Jul 21, 2026Lunan Pharmaceutical Group's first study: phase 3 study in AsthmaNew to Lunan Pharmaceutical GroupLunan Pharmaceutical Group · NCT07768891 · 416 planned · China

Ahead

  1. Jun 2028Primary completion: phase 3 study in AsthmaLunan Pharmaceutical Group · NCT07768891

TargetBeta

NR3C1 →read by rule
“Glucocorticoid receptor agonist”ChEMBL 37, by rule

Other programs on NR3C1

ProgramCompanyFurthest phaseStudies
DexamethasoneruleAbbViephase 4174
BudesonideruleAstraZenecaphase 4167
fluticasone furoateruleGlaxoSmithKlinephase 497
PrednisoneruleJohnson & Johnsonphase 465
PrednisoloneruleSanofiphase 434
betamethasone dipropionateruleLEO Pharmaphase 427
MethylprednisolonerulePfizerphase 423
dexamethasone phosphateruleeyegate-pharmaceuticals-incphase 421
vamorolonerulereveragen-biopharma-incphase 411
BetamethasoneruleLEO Pharmaphase 49
Triamcinoloneruleresearch-insight-llcphase 45
relacorilantruleCorcept Therapeuticsphase 322

Studies

All 44 led by companies developing it, newest first. Each opens its study page.

StudyPhaseStatusLed byPrimary completionSize
NCT07768891Asthma · China3RecruitingLunan Pharmaceutical GroupJun 2028416
NCT05292586Asthma · United States3CompletedChiesi FarmaceuticiJun 24, 20241,377
NCT04876677Pulmonary Disease, Chronic Obstructive · Belgium, Hungary3CompletedChiesi FarmaceuticiJan 3, 202225
NCT04886999Asthma · Italy3CompletedChiesi FarmaceuticiFeb 1, 202378
NCT04873063Healthy Adult Male Volunteers · Italy1CompletedSOFARApr 28, 202228
NCT04671355Pulmonary Disease, Chronic Obstructive4WithdrawnChiesi FarmaceuticiDec 22, 20210
NCT03835871Asthma3WithdrawnAdamis PharmaceuticalsDec 20190
NCT03834012Asthma3WithdrawnAdamis PharmaceuticalsNov 20190
NCT03268226Pulmonary Disease, Chronic Obstructive · Belgium, Hungary3CompletedChiesi FarmaceuticiJan 30, 201920
NCT02975843Pulmonary Disease, Chronic Obstructive1CompletedChiesi FarmaceuticiMar 21, 201728
NCT02148120Asthma · United Kingdom2CompletedChiesi FarmaceuticiOct 201460
NCT02119234Pulmonary Disease, Chronic Obstructive · Poland1CompletedChiesi FarmaceuticiFeb 201536
NCT02040779Asthma · United States3CompletedTeva Pharmaceutical IndustriesDec 24, 2014273
NCT02040766Asthma · United States, Croatia, Mexico and more3CompletedTeva Pharmaceutical IndustriesFeb 2016628
NCT02040597Pulmonary Disease, Chronic Obstructive · Poland1CompletedChiesi FarmaceuticiApr 201542
NCT02031640Asthma · United States, Germany, Hungary and more3CompletedTeva Pharmaceutical IndustriesNov 20141,113
NCT01925950Chronic Gastrointestinal Graft vs Host Disease · United States2TerminatedSoligenixMay 20152
NCT01917331Pulmonary Disease, Chronic Obstructive · Hungary3CompletedChiesi FarmaceuticiJan 14, 20161,368
NCT01783548Rhinitis, Allergic · United States3CompletedTeva Pharmaceutical IndustriesOct 2013547
NCT01803087Asthma · Poland2CompletedChiesi FarmaceuticiOct 201260
NCT01658891Asthma in Children · Denmark3WithdrawnChiesi FarmaceuticiNov 20150
NCT01691677Acute Rhinosinusitis · Italy3CompletedChiesi FarmaceuticiJan 2014166
NCT01584492Asthma · Poland, Ukraine2CompletedChiesi FarmaceuticiFeb 201359
NCT01475032Asthma · Bulgaria, France, Germany and more3CompletedChiesi FarmaceuticiSep 2012638
NCT01307319Rhinitis, Allergic, Seasonal · United States3CompletedTeva Pharmaceutical IndustriesJul 2011715
NCT01134705Rhinitis, Allergic, Perennial · United States3CompletedTeva Pharmaceutical IndustriesOct 2010474
NCT01133626Rhinitis, Allergic, Perennial · United States3CompletedTeva Pharmaceutical IndustriesSep 2010107
NCT01073384Enteritis · United States2CompletedSoligenixJan 201216
NCT01024608Rhinitis, Allergic, Seasonal · United States3CompletedTeva Pharmaceutical IndustriesFeb 28, 2010340
NCT00988247Rhinitis, Allergic, Perennial · United States3CompletedTeva Pharmaceutical IndustriesFeb 28, 2011529
NCT00926575Acute Gastrointestinal Graft vs Host Disease · United States3TerminatedSoligenixDec 2011140
NCT00861926Asthma · Bulgaria, Croatia, Czechia and more3CompletedChiesi FarmaceuticiDec 7, 20101,714
NCT00854360Rhinitis, Allergic, Seasonal · United States2CompletedTeva Pharmaceutical IndustriesMay 2009487
NCT00497523Asthma · Poland, Ukraine3CompletedChiesi Farmaceutici283
NCT00497237Asthma · Bulgaria, Italy, Ukraine3CompletedChiesi FarmaceuticiMar 2010382
NCT00476268Asthma3CompletedChiesi FarmaceuticiJan 2005824
NCT00413387Asthma · Austria, Poland, Ukraine3CompletedChiesi FarmaceuticiAug 2005219
NCT00394368Asthma · Poland, Ukraine3CompletedChiesi Farmaceutici180
NCT00382889Asthma · Austria, Italy, Poland and more3CompletedChiesi Farmaceutici480
NCT00250341Asthma · United States4CompletedTeva Pharmaceutical IndustriesSep 30, 200734
NCT00233896Graft vs Host Disease · United States3CompletedEnteron Pharmaceuticals130
NCT00109668Asthma · United States, Puerto Rico3CompletedTeva Pharmaceutical IndustriesSep 30, 2006415
NCT00094016Asthma · United States, Puerto Rico3CompletedTeva Pharmaceutical IndustriesJun 30, 2006440
NCT00071552Asthma · United States4TerminatedTeva Pharmaceutical IndustriesJul 31, 200649

How it is read

Names in the registry

  • “Beclomethasone dipropionate”, 6 entries
  • “Beclometasone/Formoterol/Glycopyrrolate”, 2 entries
  • “beclomethasone”, 2 entries
  • “beclomethasone dipropionate plus formoterol fumarate combination”, 2 entries
  • “Beclometasone dipropionate/Formoterol Fumarate/Glycopyrronium”, 2 entries

Conditions, from the studies’ own filings

First seen by our ledger Nov 13, 2026.

What this can’t show

  • Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
  • Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
  • Primary completion dates are the sponsors’ estimates and often move.
  • A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.